![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/47 | (2013.01) |
A61K 31/47 | (2006.01) | ||
A61K 31/4709 | (2006.01) | ||
A61K 31/4709 | (2013.01) | ||
A61K 31/497 | (2006.01) | ||
A61K 31/497 | (2013.01) | ||
A61K 31/5377 | (2006.01) | ||
A61K 31/5377 | (2013.01) | ||
C07D 215/38 | (2006.01) | ||
G01N 33/5023 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
G01N 33/5055 | (2013.01) | ||
A61P 1/00 | (2006.01) | ||
C12Q2600/158 | (2013.01) | ||
A61P 19/02 | (2006.01) | ||
C12Q2600/178 | (2013.01) | ||
C12Q 1/6883 | (2013.01) | ||
A61P 25/00 | (2006.01) | ||
G01N 33/50 | (2006.01) | ||
C12Q2600/136 | (2013.01) | ||
C07D 215/38 | (2013.01) | ||
C12Q 1/68 | (2018.01) | ||
C07D 401/12 | (2013.01) | ||
A61P 1/00 | (2018.01) | ||
A61P 1/04 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 11/06 | (2018.01) | ||
A61P 17/00 | (2018.01) | ||
A61P 17/06 | (2018.01) | ||
A61P 19/02 | (2018.01) | ||
A61P 21/00 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 25/16 | (2018.01) | ||
A61P 25/28 | (2018.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 37/06 | (2018.01) | ||
A61P 9/10 | (2018.01) |
(11) | Patento numeris | 3998070 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 21211115.7 |
Europos patento paraiškos padavimo data | 2015-07-17 | |
(97) | Europos patento paraiškos paskelbimo data | 2022-05-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-12-18 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
14306164 | 2014-07-17 | EP |
(72) |
TAZI, Jamal , FR
NAJMAN, Romain , FR
MAHUTEAU, Florence , FR
SCHERRER, Didier , FR
|
(73) |
ABIVAX ,
7-11 Boulevard Haussmann, 75009 Paris,
FR
Centre National de la Recherche Scientifique , 3, rue Michel-Ange, 75794 Paris Cedex 16, FR Institut Curie , 26, rue d'Ulm, 75248 Paris Cedex 05, FR UNIVERSITE DE MONTPELLIER , 163, rue Auguste Broussonnet, 34090 Montpellier, FR |
(54) | MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES |
MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES |